Metraipolis › archive › dc_f25cdb073e43

Economic impact of generic antiretrovirals in France for HIV patients' care: a simulation between 2019 and 2023 — Europe PMC PMID:35477443

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35477443
DOI
10.1186/s12913-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-10-08T01:05:20.065Z
SHA-256 of the archived text
712d92037ab05fd258b18c2eddd06b31c0a0f53579d2c7707dd6109341dd992f
Stable URL of this page
https://metraipolis.com/documento/dc_f25cdb073e43

How to cite

Economic impact of generic antiretrovirals in France for HIV patients' care: a simulation between 2019 and 2023 — Europe PMC PMID:35477443 — Europe PMC (en), https://europepmc.org/article/MED/35477443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f25cdb073e43 (Metraipolis archive dc_f25cdb073e43, sha256 712d92037ab05fd258b18c2eddd06b31c0a0f53579d2c7707dd6109341dd992f)
BibTeX
@misc{dcf25cdb073e43,
  title = {Economic impact of generic antiretrovirals in France for HIV patients' care: a simulation between 2019 and 2023 — Europe PMC PMID:35477443},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35477443},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f25cdb073e43; sha256 712d92037ab05fd258b18c2eddd06b31c0a0f53579d2c7707dd6109341dd992f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35477443. Agents can read the archived copy with the MCP tool read_document.